Results 141 to 150 of about 154,650 (346)
Aim After pancreaticoduodenectomy, 20–40% of patients develop steatotic liver disease (SLD), and steatohepatitis can be a problem. Although patatin‐like phospholipase domain‐containing 3 protein (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2 ...
Tomotaka Mori +18 more
doaj +1 more source
Obesity and its associated metabolic dysfunction and cardiovascular disease risk represent a leading cause of adult morbidity worldwide. Currently available pharmacological therapies for obesity have had limited success in reversing existing obesity and ...
Amy C. Burke +7 more
doaj +1 more source
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mouse
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in ...
L Leybaert (13303389) +11 more
core
ABSTRACT Hepatocytes perform essential physiological functions in the human body. Gaining more profound insight into the liver structure, diseases, and physiology by using in vitro models can help to propose more relevant clinical applications. Conventional in vitro liver models, such as two‐dimensional (2D) cell cultures, fail to adequately replicate ...
Seyedeh Kiana Teymorian +3 more
wiley +1 more source
A fatal case of progressive steatohepatitis, possibly chemotherapy- associated steatohepatitis related to gemcitabine [PDF]
We report the case of an 80-year-old female suffering from pancreatic cancer who developed severe non-alcoholic steatohepatitis (NASH) resulting in fatal hepatic failure after anti-cancer chemotherapy with gemcitabine.
21941 +19 more
core +1 more source
Serum ubiquitin levels in patients with nonalcoholic steatohepatitis
Background/Aims: Nonalcoholic steatohepatitis is increasingly recognized as the most common liver disease in patients with elevated liver enzymes. In the pathophysiology of nonalcoholic steatohepatitis, the first step is the lipid accumulation in the ...
Koruk, M +6 more
core
Abstract End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.
Damiano Patrono +8 more
wiley +1 more source
Alcoholic Liver Disease: A Comprehensive Review [PDF]
Alcoholic liver disease, a leading cause of morbidity, mortality, and cirrhosis, can range from simple steatosis to hepatocellular carcinoma. Multiple mechanisms such as oxidative stress, mitochondrial dysfunction, and alteration in gut-liver axis have ...
Partha Pal, Sayantan Ray
doaj
Statin use and non-alcoholic steatohepatitis in at risk individuals [PDF]
Background & Aims Excess hepatic free cholesterol contributes to the pathogenesis of non-alcoholic steatohepatitis, and statins reduce cholesterol synthesis.
Maggioni, M. +72 more
core +1 more source
: Background The reference standard for detecting non-alcoholic steatohepatitis (NASH) and staging fibrosis-liver biopsy-is invasive and resource intensive.
Vali, Yasaman +36 more
core

